QCDR

Qualified Clinical Data RegistryAcademic Research for Clinical Outcomes (ARCO) is approved as a Qualified Clinical Data Registry (QCDR) for 2017 and 2018. ARCO is a health collaborative with ReportingMD focusing on outcomes management to foster clinical quality integration. ReportingMD services and solutions assist providers from all ambulatory practices with the ability to proactively manage their patient populations through frequent automated data exchange. Together, through the collection of data from all payers and the transformation of financial and/or clinical data into meaningful results, our clients gain insight and understanding to implement improvements in clinical outcomes and patient care delivery. Specifically, we define the gaps in care needed to successfully manage patient care, identify process improvement opportunities, and facilitate the adoption of evidence-based medicine, thus changing the way physicians practice medicine. ARCO works collaboratively with various University Health Systems to promote clinically integrated environments and to ensure the utilization of clinical best practices with the goal of improving population health through evidence-based care. ReportingMD’s Clinical Quality Data services include workflow review and process optimization to enable the closure of care gaps and improvement in population health. We also provide educational opportunities for our clients with the overall goal of process and performance improvement. Our analytic and technical capabilities include use of risk-adjusted benchmarks within the Total Outcomes Management solution to allow on-going, peer-based performance evaluation and monitoring at the practice, specialty, regional, or national levels.

Key Features and Benefits:

  • Continuous feedback reports and benchmark/performance monitoring
  • Measures Optimization Evaluation (MOE) – ensures highest performing measures are selected for your organization
  • Dedicated resources to provide clinical and programmatic consultations and education to effectively improve outcomes and performance
  • Rapid implementation cycle: Data available to clients via secure portal 3 weeks from obtaining tested, approved data set
  • Population Health Monitoring assists in improving outcomes and reduces costs through Registry facilitated projects, accompanied by effective research and consultation services.
  • Assists in achieving ACO savings goals and/or Merit-based Incentive Payment System (MIPS) reporting requirements
  • Active participation in measure creation, sharing of evidence based medicine and research

As a QCDR with a certified EHR technology module, ReportingMD is ready to accept data as a specialized registry and will use that data to improve population health outcomes. ReportingMD can receive data generated from Certified EHR Technology (CEHRT) through any appropriate secure mechanism. Manual data entry into a web portal would not qualify for submission to a specialized registry.

ReportingMD will submit data through the Qualified Clinical Data Registry (QCDR) method to meet pay-for-performance program requirements.

For 2017, ARCO has 9 non-MIPS measures as well as all MIPS measures and all 64 electronic clinical quality measures (eCQMs) approved for submission for the 2017 reporting year. Below is a list of the 9 approved non-MIPS measures with associated measure specifications (link to specifications for 2017 QCDR measures is HERE):

  • ARCO3 –   Antipsychotic Use in Persons with Dementia
  • ARCO7 –   Laboratory Investigation for Secondary Causes of Fracture
  • ARCO10 – Risk Standardized Mortality Rate within 30 days following Trauma Operation
  • ARCO11 –  Head CT or MRI Scan Results for Acute Ischemic Stroke or Hemorrhagic Stroke Patients who Received Head CT or MRI Scan Interpretation within 45 minutes of ED Arrival
  • ARCO12 – Venous Thromboembolism (VTE) Prophylaxis
  • ARCO13 – Ischemic stroke patients management
  • ARCO14 – Gout: ULT Therapy
  • NOF12 –    Median Time to Pain Management for Long Bone Fracture
  • ACR7 –      Gout: Serum Urate Target

For 2018, ARCO has 13 non-MIPS measures as well as all MIPS measures and all 64 electronic clinical quality measures (eCQMs) approved for submission for the 2018 reporting year. Below is a list of the 13 aproved 2018 Non-MIPS Measures with associated measure specifications (link to specifications for 2018 QCDR measures is HERE):

  • ARCO3 –   Antipsychotic Use in Persons with Dementia
  • ARCO10 – Risk Standardized Mortality Rate within 30 days following Trauma Operation
  • ARCO11 –  Head CT or MRI Scan Results for Acute Ischemic Stroke or Hemorrhagic Stroke Patients who Received Head CT or MRI Scan Interpretation within 45 minutes of ED Arrival
  • ARCO12 – Venous Thromboembolism (VTE) Prophylaxis
  • ARCO13 – Ischemic stroke patients management
  • NOF12 –   Median Time to Pain Management for Long Bone Fracture
  • ACR7 –      Gout: Serum Urate Target
  • ARCO15 – Diabetes: Nutritional, Weight Loss Counseling, Reduction of Sedentary Behavior
  • ARCO16 – Dyspnea or Heart Failure: Use of BNP or NT- pro BNP screening
  • ARCO17 – Heart Failure: Use of Aldosterone Antagonists and Diuretics for Symptom Control
  • ARCO18 – Heart Failure: Counseling on Self-care, Including Monitoring Blood Pressure, Weight, Sodium Intake, and Physical Activity
  • ARCO19 – Promoting self-care for prevention and management of chronic conditions
  • ARCO20 – Percentage of patients using self-monitoring with mobile technology or eHealth solutions to manage their diabetes, hypertension, sodium intake, nutritional status, physical activity, tobacco use, alcohol use, and sedentary behaviors